PGLA-(Polyglactine-910) Surgical Sutures are absorbable, sterile sutures designed for wound closure in general surgery, orthopedics, gynecology, and dental procedures. Made from polyglactide-co-glycolide (PGLA 910), a biodegradable polymer, these sutures eliminate the need for suture removal, reducing patient discomfort and follow-up visits.
| Quantity: | |
|---|---|
USP 2--6/0
PGLA 910 sutures are braided for enhanced tensile strength and knot security, ensuring reliable wound support during the healing process. The absorbable material is metabolized by the body into harmless byproducts (carbon dioxide and water) over time, eliminating foreign body reactions. Each suture is attached to a 45mm 1/2 circle round-bodied needle, facilitating easy tissue penetration and precise suturing. The sterile EO-sterilized packaging ensures safe clinical use.
The global absorbable surgical sutures market is valued at $3.2 billion in 2024 and is expected to grow at a CAGR of 7.3% through 2030. PGLA-based sutures are gaining traction due to their predictable absorption rate and biocompatibility. The rising number of surgical procedures (estimated at 313 million globally annually) and the preference for minimally invasive surgeries drive demand. Hospitals, surgical centers, and clinics are the primary end-users, with a growing focus on reducing post-operative complications.
Parameter | Specification |
Brand | INTRAG MEDICAL TECHS |
Material | Polyglactine-910 (PGLA 910) |
Suture Size | USP 2 to 6/0 (Metric 5 to 1) |
Length | 75cm |
Needle Type | 45mm 1/2 Circle, round-bodied |
Packaging | 12 PCS per sterile blister pack |
Sterilization Method | EO (Ethylene Oxide) sterilization |
Absorption Rate | Complete absorption in 60-90 days |
Certifications | ISO 10993, USP Class VI, CE |
Absorbable Material: Biodegradable PGLA 910 eliminates suture removal, reducing patient pain and healthcare costs.
Braided Construction: Offers superior tensile strength and knot security, preventing suture breakage during healing.
Precision Needle Design: 45mm 1/2 circle round-bodied needle ensures smooth tissue penetration and minimal trauma.
Sterile Packaging: EO sterilization achieves SAL 10⁻⁶, ensuring safe use in sterile surgical environments.
Multiple Sizes: USP 2 (heavy tissue) to 6/0 (fine tissue) covers diverse surgical needs.
These surgical sutures comply with ISO 10993 (biological evaluation of medical devices) and USP Class VI standards for biocompatibility. The tensile strength retention meets surgical requirements, providing adequate wound support for 3-4 weeks (critical healing period). The absorption rate is predictable, with no adverse tissue reactions. The product is also compliant with CE medical device regulations, ensuring global market access.
Complete absorption occurs in 60-90 days, depending on the patient’s tissue healing rate and suture size.
No, absorbable sutures are not recommended for infected or contaminated wounds. Use non-absorbable sutures in such cases to avoid delayed healing.
Yes, PGLA 910 sutures are biocompatible and safe for pediatric use. The appropriate size (e.g., 4/0 to 6/0) should be selected based on the tissue type.
Store in a cool, dry place (10-25°C) away from direct sunlight and moisture. Keep the blister packs sealed until use to maintain sterility.
PGLA 910 sutures are braided for enhanced tensile strength and knot security, ensuring reliable wound support during the healing process. The absorbable material is metabolized by the body into harmless byproducts (carbon dioxide and water) over time, eliminating foreign body reactions. Each suture is attached to a 45mm 1/2 circle round-bodied needle, facilitating easy tissue penetration and precise suturing. The sterile EO-sterilized packaging ensures safe clinical use.
The global absorbable surgical sutures market is valued at $3.2 billion in 2024 and is expected to grow at a CAGR of 7.3% through 2030. PGLA-based sutures are gaining traction due to their predictable absorption rate and biocompatibility. The rising number of surgical procedures (estimated at 313 million globally annually) and the preference for minimally invasive surgeries drive demand. Hospitals, surgical centers, and clinics are the primary end-users, with a growing focus on reducing post-operative complications.
Parameter | Specification |
Brand | INTRAG MEDICAL TECHS |
Material | Polyglactine-910 (PGLA 910) |
Suture Size | USP 2 to 6/0 (Metric 5 to 1) |
Length | 75cm |
Needle Type | 45mm 1/2 Circle, round-bodied |
Packaging | 12 PCS per sterile blister pack |
Sterilization Method | EO (Ethylene Oxide) sterilization |
Absorption Rate | Complete absorption in 60-90 days |
Certifications | ISO 10993, USP Class VI, CE |
Absorbable Material: Biodegradable PGLA 910 eliminates suture removal, reducing patient pain and healthcare costs.
Braided Construction: Offers superior tensile strength and knot security, preventing suture breakage during healing.
Precision Needle Design: 45mm 1/2 circle round-bodied needle ensures smooth tissue penetration and minimal trauma.
Sterile Packaging: EO sterilization achieves SAL 10⁻⁶, ensuring safe use in sterile surgical environments.
Multiple Sizes: USP 2 (heavy tissue) to 6/0 (fine tissue) covers diverse surgical needs.
These surgical sutures comply with ISO 10993 (biological evaluation of medical devices) and USP Class VI standards for biocompatibility. The tensile strength retention meets surgical requirements, providing adequate wound support for 3-4 weeks (critical healing period). The absorption rate is predictable, with no adverse tissue reactions. The product is also compliant with CE medical device regulations, ensuring global market access.
Complete absorption occurs in 60-90 days, depending on the patient’s tissue healing rate and suture size.
No, absorbable sutures are not recommended for infected or contaminated wounds. Use non-absorbable sutures in such cases to avoid delayed healing.
Yes, PGLA 910 sutures are biocompatible and safe for pediatric use. The appropriate size (e.g., 4/0 to 6/0) should be selected based on the tissue type.
Store in a cool, dry place (10-25°C) away from direct sunlight and moisture. Keep the blister packs sealed until use to maintain sterility.
